Simple and rapid quantification of the non-nucleoside reverse transcriptase inhibitors nevirapine, delavirdine, and efavirenz in human blood plasma using high-performance liquid chromatography with ultraviolet absorbance detection

被引:36
作者
Rezk, NL [1 ]
Tidwell, RR [1 ]
Kashuba, ADM [1 ]
机构
[1] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC 27599 USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2002年 / 774卷 / 01期
关键词
nevirapine; delavirdine; efavirenz;
D O I
10.1016/S1570-0232(02)00210-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple reversed-phase high-performance liquid chromatography assay for the simultaneous quantitative determination of three HIV non-nucleoside reverse transcriptase inhibitors (nevirapine, delavirdine, and efavirenz) in human blood plasma is described. The method was validated over the range of 10 ng/ml to 50 mug/ml for nevirapine, 25 ng/ml to 25 mug/ml for delavirdine, and 10 ng/ml to 10 mug/ml for efavirenz. The method is accurate (average accuracies over eight concentrations ranging from 87.3 to 113%), and precise (within-day and between-day precision measures ranging from 0.12 to 7.9% and 0.26 to 5.9%, respectively). All three non-nucleoside reverse transcriptase inhibitors proved to be stable under various conditions, Due to its simplicity, this assay can readily be used for investigational or clinical monitoring of plasma concentrations. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:79 / 88
页数:10
相关论文
共 19 条
[1]   Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography [J].
Aymard, G ;
Legrand, M ;
Trichereau, N ;
Diquet, B .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 744 (02) :227-240
[2]   Protease inhibitors in patients with HIV disease - Clinically important pharmacokinetic considerations [J].
Barry, M ;
Gibbons, S ;
Back, D ;
Mulcahy, F .
CLINICAL PHARMACOKINETICS, 1997, 32 (03) :194-209
[3]   Effect of fluconazole on the steady-state pharmacokinetics of delavirdine in human immunodeficiency virus-positive patients [J].
Borin, MT ;
Cox, SR ;
Herman, BD ;
Carel, BJ ;
Anderson, RD ;
Freimuth, WW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :1892-1897
[4]  
BURGER DM, 1998, 12 WORLD AIDS C GEN, P42275
[5]   High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction [J].
Dailly, E ;
Thomas, L ;
Kergueris, MF ;
Jolliet, P ;
Bourin, M .
JOURNAL OF CHROMATOGRAPHY B, 2001, 758 (02) :129-135
[6]   Determination of nevirapine, an HIV-1 non-nucleoside reverse transcriptase inhibitor, in human plasma by reversed-phase high-performance liquid chromatography [J].
Hollanders, RMF ;
Kolmer, EWJV ;
Burger, DM ;
Wuis, EW ;
Koopmans, PP ;
Hekster, YA .
JOURNAL OF CHROMATOGRAPHY B, 2000, 744 (01) :65-71
[7]   High-performance liquid chromatographic method for the determination of HIV-1 non-nucleoside reverse transcriptase inhibitor efavirenz in plasma of patients during highly active antiretroviral therapy [J].
Langmann, P ;
Schirmer, D ;
Väth, T ;
Zilly, M ;
Klinker, H .
JOURNAL OF CHROMATOGRAPHY B, 2001, 755 (1-2) :151-156
[8]   Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction [J].
Marzolini, C ;
Telenti, A ;
Buclin, T ;
Biollaz, J ;
Decosterd, LA .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 740 (01) :43-58
[9]   Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients [J].
Marzolini, C ;
Telenti, A ;
Decosterd, LA ;
Greub, G ;
Biollaz, J ;
Buclin, T .
AIDS, 2001, 15 (01) :71-75
[10]  
NACENTA MS, 2001, J CHROMATOGR, V763, P53